Blanchard, Andy D.
GlaxoSmithKline (United Kingdom) · GlaxoSmithKline Research & Development Limited (United Kingdom)
2 papers on CoChatORCID 0000-0002-8663-4762
Most cited papers
- Verified
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Woodcock, H. V., Eley, J. D., Guillotin, D., Platé, M., Nanthakumar, C. B., Martufi, M., Peace, S., Joberty, G., Poeckel, D., Good, R. B., et al. (2019) · Nature Communications
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPI3K/AKT/mTOR signaling in cancer
Cited by 224
- Verified
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Mercer, P. F., Woodcock, H. V., Eley, J. D., Platé, M., Sulikowski, M. G., Durrenberger, P. F., Franklin, L., Nanthakumar, C. B., Man, Y., Genovese, F., et al. (2016) · Thorax
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases
Cited by 206
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free